Arcutis Biotherapeutics Stock (NASDAQ: ARQT) stock price, news, charts, stock research, profile.
You can purchase shares of Arcutis Biotherapeutics (NASDAQ:ARQT) through any online brokerage.
Other companies in Arcutis Biotherapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Upstream Bio (NASDAQ:UPB) and Cogent Biosciences (NASDAQ:COGT).
Arcutis Biotherapeutics has a consensus price target of $25.90.
The stock price for Arcutis Biotherapeutics (NASDAQ: ARQT) is $9.26 last updated November 15, 2024 at 4:00 PM EST.
There are no upcoming dividends for Arcutis Biotherapeutics.
Arcutis Biotherapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Arcutis Biotherapeutics.
Arcutis Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.